看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。5 {9 ^) Q; M- O5 X4 O, X. T7 [
1 c8 m7 }: H1 d3 o( y
8 e) R9 T. k! ]1 @; o RCurrently available feasibility data for possible combination strategies.
/ a- N q4 U( {* X& Q————————————————————————————————* x8 w8 c% e3 @7 Z" L- N
Combination Feasibility according to preliminary data
9 i% I* z8 J; q. D0 g( D——————————————————————————————————
$ S& V$ O% ^4 X) H, c# `Bevacizumab + sorafenib Yes, reduced dose $ \% K W* ]8 Y* Z( [6 M, T! W
Bevacizumab + sunitinib† No % s9 r7 ~- o @/ G1 P; c0 ^
Bevacizumab + temsirolimus Yes
. A" p2 n! n/ S7 U0 |8 {Bevacizumab + everolimus Yes 8 g+ h# K5 m. T+ ^# `% @4 C5 o
Sorafenib + sunitinib ? 9 n: o4 s, u0 _. Q
Sorafenib + temsirolimus Yes, reduced dose * s" m+ u" i% D" S( o6 V
Sorafenib + everolimus Yes, reduced dose
) Q7 A& }" r6 ]2 \Sunitinib + temsirolimus† No
- ~: j$ X( C" V. MSunitinib + everolimus ?
8 ~5 S% t- i3 X; aTemsirolimus + everolimus ? 6 q. b7 d& E; G1 o/ Q5 ]/ b
————————————————————3 V t6 e; M7 K$ I M
†Led to US FDA warning.( V0 |4 U: t& ?
?: As yet unattempted combination." \2 ~: p9 j0 b, c
|